\
&
Contact us
Published on | 9 months ago
Programmes Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies European Digital Innovation HubsThe upcoming calls from the Digital Europe Main Work Programme have been published on the Funding & Tenders Portal of the European Commission.
The following 10 call topics are expected to open for submission on 15 April 2025, deadline to submit proposals will be 2 September 2025:
Furthermore, a call aiming at the Consolidation of the network of European Digital Innovation Hubs (EDIHs with reinforced AI focus) will open on 3 April 2025 and close on 14 May 2025.
NCP Flanders organises an info session on these upcoming calls on 14 April.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
The European Cybersecurity Competence Centre (ECCC) has opened a call for tenders to set up a European testing infrastructure for post-quantum cryptography (PQC). Open to applicants across the European Economic Area, the contract is worth EUR 25 million and covers IT services including development and support. The submission deadline is 20 Februa... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.